C
Cocrystal Pharma, Inc. (COCP)
NCM – Real Time Price. Currency in USD
1.02
+0.01 (0.99%)
At close: Jun 26, 2026, 4:00 PM EDT
1.00
-0.02 (-1.96%)
After-hours: Jun 26, 2026, 6:11 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
1.02
+0.01 (0.99%)
At close: Jun 26, 2026, 4:00 PM EDT
1.00
-0.02 (-1.96%)
After-hours: Jun 26, 2026, 6:11 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $4.8M significantly exceed its total debt $1.4M, ensuring strong financial flexibility
Total current assets $5.9M exceed Total current liabilities $2.2M, highlighting excellent liquidity
Debt-to-equity ratio (0.3) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.66 | 6.05 | 10 | |
| Quick ratio | 2.66 | 5.63 | 10 | |
| Debt to Equity | 0.35 | 0.30 | 7.0 | |
| Debt to Assets | 0.19 | 1.04 | 8.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | 225K |
| Gross Profit | -388K | 1M | -126K | -376K | 9K |
| Operating Income | -18M | -21M | -18M | -9M | -9M |
| Net Income | -39M | -18M | -18M | -9M | -9M |
| EBITDA | -18M | -23M | -18M | -9M | -9M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 17.5 | 5.0 |
| Next quarter | N/A | 7.89 | 3.5 |
| Current year | N/A | 12.18 | 4.0 |
| Next year | N/A | 6.57 | 3.0 |
| Weighted average score | 3.9 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 5.23 | -6.24 | -17.42 | 4.3 |
| Y/Y | 999 | 0.09 | 26.09 | 27.99 | 8.0 |
| 3y average | 999 | 35.3 | 41.16 | 23.33 | 10 |
| 5y average | 779.2 | -22.97 | -3.81 | -5.04 | 3.3 |
| Weighted average score | 6.4 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |